Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 6Phase 1/2 5Phase 3 4Phase NA 2Phase 4 1

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 23Gastrointestinal 13Sarcoma 9Breast 4Thoracic 2Tumor-Agnostic 1NET 1Endocrine 1

Conditions

Breast Neoplasms 4

Interventions

Cyclophosphamide 171Docetaxel 164Paclitaxel 160Trastuzumab 152Capecitabine 130Tamoxifen 119Letrozole 105Epirubicin 93Doxorubicin 83Anastrozole 83exemestane 77Fulvestrant 75Carboplatin 64Fluorouracil 63Radiotherapy 61pertuzumab 59Gemcitabine 55Vinorelbine 43Goserelin 39eribulin 36130-nm albumin-bound paclitaxel 36palbociclib 32Bevacizumab 32ribociclib 30Zoledronic Acid 29Lapatinib 29Methotrexate 28Drug Therapy 28Chemotherapy, Adjuvant 28Ado-Trastuzumab Emtansine 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Sunitinib × Breast × Clear all
NCT00373256 2012-09-10

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

Pfizer

Phase 3 Completed
488 enrolled 12 charts
Breast

Breast Neoplasms

NCT00393939 2012-07-19

SUN 1064

Pfizer

Phase 3 Completed
594 enrolled 11 charts
Breast

Breast Neoplasms

NCT00435409 2012-06-26

A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer

Pfizer

Phase 3 Completed
442 enrolled 12 charts
Breast

Breast Neoplasms

NCT00373113 2012-06-25

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine

Pfizer

Phase 3 Terminated
482 enrolled 12 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡